Skip to main content

Peer Review reports

From: Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial

Original Submission
18 Mar 2022 Submitted Original manuscript
13 May 2022 Reviewed Reviewer Report - Kirsty Loudon
14 Jun 2022 Author responded Author comments - Ivor Russel Lee
Resubmission - Version 2
14 Jun 2022 Submitted Manuscript version 2
Publishing
24 Jun 2022 Editorially accepted
19 Jul 2022 Article published 10.1186/s13063-022-06495-3

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215